CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 1,200 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $6 | +50.0% | 1,200 | -7.7% | 0.00% | – |
| Q1 2023 | $4 | -85.7% | 1,300 | -64.9% | 0.00% | -100.0% |
| Q4 2022 | $28 | -99.9% | 3,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $29,000 | -49.1% | 3,700 | -5.1% | 0.00% | -50.0% |
| Q2 2022 | $57,000 | +58.3% | 3,900 | +50.0% | 0.00% | +100.0% |
| Q1 2022 | $36,000 | -92.0% | 2,600 | -95.0% | 0.00% | -90.0% |
| Q4 2021 | $451,000 | +1.1% | 52,340 | +138.8% | 0.02% | 0.0% |
| Q3 2021 | $446,000 | -65.0% | 21,914 | -76.9% | 0.02% | -66.1% |
| Q2 2021 | $1,275,000 | -25.4% | 95,036 | +130.1% | 0.06% | -29.8% |
| Q1 2021 | $1,709,000 | -36.8% | 41,300 | -53.0% | 0.08% | -34.9% |
| Q4 2020 | $2,706,000 | +68.0% | 87,900 | +17.2% | 0.13% | +30.3% |
| Q3 2020 | $1,611,000 | – | 75,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,709,781 | $13,500,000 | 10.67% |
| FOX RUN MANAGEMENT, L.L.C. | 31,522 | $248,000 | 0.10% |
| Green Alpha Advisors, LLC | 12,598 | $99,000 | 0.08% |
| Quantamental Technologies LLC | 10,846 | $85,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 49,034 | $386,000 | 0.03% |
| Virtus ETF Advisers LLC | 7,733 | $61,000 | 0.02% |
| XTX Topco Ltd | 12,040 | $95,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 55,320 | $436,000 | 0.01% |
| TWINBEECH CAPITAL LP | 46,360 | $365,000 | 0.01% |
| Man Group plc | 281,996 | $2,222,000 | 0.01% |